Alkem Laboratories Limited, a pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and internationally. The company offers branded generics, generic drugs, active pharmaceutical ingredients, and biosimilars, and nutraceuticals in acute and chronic therapeutic areas comprising anti-infective, gastroenterology, pain management, iron deficiency, diabetology, central nervous system, anti-osteoporosis, gynecology, respiratory, ophthalmology, rheumatology, urology, dermatology, cardiology, neurology, and oncology. It also provides vitamins, minerals, and nutrients; cough syrups, hepatoprotective tonic, anti-dandruff shampoo, mouth wash, pregnancy detection kits, and condoms; and anti-bloating syrups, tablets, and powder. The company was incorporated in 1973 and is headquartered in Mumbai, India.
| Current Price | ₹5,239.00 |
|---|---|
| Market Cap | ₹62,640 Cr |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Medicinal Chemicals and Botanical Products |
| P/E Ratio | 27.2 |
| Return on Equity | 17.56% |
| 52-Week Range | ₹4,716.20 – ₹5,933.50 |
| Beta (1Y) | 0.35 |
| Dividend Yield | 0.38% |
1. Pharmaceuticals-100%
Alkem Laboratories Ltd is trading at ₹5,239.00, with a market capitalisation of ₹62,640 Cr.
Alkem Laboratories Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Medicinal Chemicals and Botanical Products).
Alkem Laboratories Ltd has a P/E of 27.2 and a return on equity of 17.56%.